Little is known about factors influencing infant perfluorinated alkyl acid (PFAA) concentrations. Associations between serum PFAA concentrations in 2-4-month-old infants (n=101) and determinants were investigated by multiple linear regression and General Linear Model (GLM) analysis. In exclusively breastfed infants, maternal serum PFAA concentrations 3 weeks after delivery explained 13% (perfluoroundecanoic acid, PFUnDA) to 73% (perfluorohexane sulfonate, PFHxS) of infant PFAA concentration variation. Median infant/maternal ratios decreased with increasing PFAA carbon chain length from 2.8 for perfluoroheptanoic acid (PFHpA) and perfluorooctanoic acid (PFOA) to 0.53 for PFUnDA, and from 1.2 to 0.69 for PFHxS and perfluorooctane sulfonate (PFOS). Infant PFOA, perfluorononanoic acid (PFNA) and PFOS increased 0.7-1.2% per day of gestational age.
TOC Graphic Introduction
Per-and polyfluoroalkyl substances (PFASs) are synthetic fluorinated substances used in numerous commercial applications and occurring ubiquitously in humans and the environment. Sources of human exposure include food, drinking water, dust, air and the use of PFAS-containing consumer products. [1] [2] [3] [4] Among the ~3000 known PFASs, 5 perfluoroalkyl acids (PFAAs) are of greatest concern due to their persistence and chain length-dependent bioaccumulation potential. 6 PFAAs may be formed from degradation of other PFASs (commonly referred to as PFAA precursors). 7, 8 PFAAs could cross the placenta and are excreted in mother´s milk. [9] [10] [11] Modeling of infant exposure to some PFAAs suggests that in utero exposure and breastfeeding are important determinants of blood concentrations. 12, 13 Food, drinking water, dust and air contribute to exposure when the child gets older. 4, [14] [15] [16] [17] High early life exposure to some
The aim of the present study was to investigate maternal to infant transfer of PFHxS (linear and branched isomers), PFOS (linear and branched isomers), perfluoroheptanoic acid (PFHpA), PFOA, PFNA, perfluorodecanoic acid (PFDA), and perfluoroundecanoic acid (PFUnDA), as well as influence of potential determining factors of infant serum concentrations, such as maternal PFAA concentrations close to delivery, duration of in utero exposure (days of gestational age at delivery), duration of breastfeeding, infant weight gain, and maternal exposure to PFAA-contaminated drinking water.
Methods

Study Population
The study is based on samples and data collected within the POPUP cohort (Persistent Organic Pollutants in Uppsala Primiparas), an on-going investigation of POPs in first-time mothers and their children that started in 1996. 22 The present study is based on recruitment of mother/child pairs 1996-1999. From early fall 1996 to May 1999, 395 randomly selected primipara women in late pregnancy were asked to participate in the study. 23 The Swedish speaking women had been recruited in early pregnancy as controls in a case-control study of caffeine as a risk factor for miscarriage. 24 In total 325 women (82%) agreed to participate in the POPUP study.
The participating women were asked if a maternal blood sample could be taken 3 weeks after delivery and an infant sample about 3 months after delivery. The mothers were Swedishborn and had singleton births with no birth defects. Almost all women had a full-term pregnancy (37-42 weeks), except in a few cases with the shortest gestational age being 35
weeks and the longest 43 weeks. Women in the POPUP cohort are homogenous regarding ethnic background. In 2006, only about 4% of the Swedish population had one or two foreign-born parents. 25 Maternal sampling 3 weeks after delivery was accepted by 211 participants.
Infant sampling was accepted by 138 participants. Due to limited blood volumes 101 maternal and 107 infant samples were available for PFAA analyses (Table 1 ). In total 101 matched mother/infant samples were available. Informed consent was obtained from all participating women. The study was approved by the Ethics Committee of the Medical Faculty at Uppsala University (2004:M-177).
Interviews, Questionnaires and Blood sampling
In-person interviews, using a structured questionnaire, were conducted at 6-12 and 32-34 completed gestational weeks. 24 Height of the women was measured and women were weighed on both interview occasions. Data on maternal characteristics included age, pre-pregnancy body mass index (BMI), years of education, place of residence, and smoking habits. At the infant sampling, the mothers answered a self-administered questionnaire including questions about delivery, and personal characteristics not covered by the interviews, such as data on breast-feeding. Vacutainer ® or Vacuette ® serum tubes were used for blood sampling, and after separation serum was stored at -20°C until analysis.
Chemical Analyses
The target analytes included C4, C6 and C8 perfluoroalkane sulfonic acids (PFSAs; PFBS, PFHxS, PFOS) and C6-C15 perfluoroalkyl carboxylic acids (PFCAs; PFHxA, PFHpA, PFOA, PFNA, PFDA, PFUnDA, PFDoDA, PFTrDA, PFTeDA, PFPeDA; for details see Supporting Information, Table A1 ). The serum samples were analyzed as described previously. 26 In short, serum (0.1 g for infants and 0.5 g for adults) was spiked with internal standards (Supporting Information, Table A2 ) and extracted with acetonitrile (Honeywell CHROMASOLV™, ≥99.95% purity) in an ultrasonic bath. The concentrated extract underwent dispersive clean-up with graphitized carbon (Supelclean™ ENVI-Carb™, Sigma-Aldrich). Aqueous ammonium acetate (2mM; EMSURE®, Sigma-Aldrich) and volumetric standards ( 13 C8-PFOS and 13 C8-PFOA; both from Wellington Labs) were added before instrumental analysis on an Acquity ultra performance liquid chromatography system (UPLC) coupled to a Xevo TQ-S tandem mass spectrometer (both Waters Corp., Milford, MA, U.S.) operated in negative electrospray ionization, multiple reaction monitoring mode. The mobile phase consisted of water and acetonitrile (ACN; both containing 2mM ammonium acetate), with the relative proportions varied under gradient conditions. ACN-based mobile phases such as that used here are highly effective at removing bile acid interferences which may affect PFOS and PFHxS analysis. [27] [28] [29] Further, instrumental parameters are provided in Supporting Information (Table A2) .
Quantification was performed by isotope dilution using a 5-point external calibration curve (linear, 1/x weighting), which was run before and after samples. For most targets, analogous isotopically labelled internal standards were available. For PFBS, PFTrDA, PFTeDA, and
PFPeDA, a structurally similar internal standard was used (Supporting Information, Table   A2 ). For PFHxS and PFOS, the linear isomer and the sum of all branched isomers (as one signal) were quantified separately using a linear isomer calibration curve. For PFOS, concentrations obtained from the m/z 499/80 and 499/99 ions were averaged, which provides a reasonable estimate of the weight % branched (%br) content in the absence of isomerspecific quantification. 30 PFHxS was also monitored using m/z 399/80 and 399/99 ions; however, since the branched isomer peak in the latter transition was often below method detection limits (MDLs), concentrations were only reported from the m/z 399/80 transition.
Both a procedural blank (0.1 or 0.5 mL Milli-Q water) and QC sample (pooled human serum analyzed repeatedly in-house) were included with every batch of samples (see Supporting Information, Table A3 , for QC performance metrics). In addition, concentrations determined in n = 3 replicates of NIST SRM 1957 were compared to reference values to assess the accuracy of the method (results provided in Supporting Information Tables A4 and   A5 In separate general linear model (GLM) analyses, using all participating mother/infant pairs, the influence of breastfeeding on infant PFAA concentration was investigated. Maternal PFAA concentration was used as a covariate in the GLM model, and infants were divided into a group that were exclusively bottle-fed from birth to sampling, a group with mixed breast-/bottle-feeding, and infants that were exclusively breastfed.
As only three of the formula-fed infants were living in a city district that received contaminated drinking water, it was not possible to statistically analyze the influence of direct drinking water exposure from formula feeding. Instead, the influence of maternal drinking water PFAA exposure on infant PFAA concentrations was investigated by grouping participants according to home address in city districts receiving drinking water with different contributions from PFAA-contaminated production well water. Uppsala County and the City of Uppsala can be divided into different drinking water districts depending on proportion of contaminated drinking water distributed to the districts. 31 There were two districts that did not receive any water from the contaminated wells from 1996 to 1999, comprised of i) areas outside the City of Uppsala and ii) District 1 within the city. District 2 in the City of Uppsala received drinking water containing <10% water from contaminated wells, District 3 received 10-90% contaminated water, and District 4 received >90% water from contaminated wells. 31 GLM analysis was used to calculate adjusted means of PFAA concentrations for the different city districts, with "days of gestational age", "infant weight gain after birth" and "duration of Logarithmically-transformed infant PFAA concentrations were used in the regression and GLM analyses, since the distribution of data closely followed a log-normal distribution.
Observations with standardized residuals ≥3 were excluded from regression and GLM analysis due to their large influence on the results. The statistical significance level was set to p≤0.05.
Results and Discussion
Serum Concentrations in Infants and Their Mothers
PFOS showed the highest median concentration followed by PFOA, PFHxS, PFNA, PFDA and PFUnDA in both infants and mothers ( Table 2) . Concentrations of short-chain PFBS,
PFHxA and PFHpA were in many cases <MDL. Among the long-chain PFCAs (>7 fluorinated carbon atoms) median concentrations decreased with increasing chain length in both infants and mothers, with >50% of concentrations below MDL for PFDoDA, PFTrDA, PFTeDA and PFPeDA ( Table 2 ). The observed concentrations differ from those reported for 6-month-old infants from Germany, 21 the only previously published infant study we could find in the literature. Different sampling periods (present study:1996-99, German study: [2007] [2008] [2009] ) and ages of the infants (present study:2-4 months, German study: 6 months) are most likely important determinants of the observed differences.
To our knowledge, no other study has reported isomer-specific data on PFHxS and PFOS for infants. We found similar %br PFOS and PFHxS in mothers and infants ( Table 2 ),
suggesting that infant isomer patterns to a large extent are dependent on maternal patterns. In
Canadian mothers, median %br PFOS (36%) was similar to that of Swedish mothers, although Canadian mothers were sampled almost 10 years after the Swedish mothers. 32 In maternal serum from China, sampled 2015-2016, branched PFHxS accounted for 14%
(median) of the total PFHxS and branched PFOS 17% of total PFOS. 33 A comparison of maternal %br PFHxS and PFOS between studies is hampered by differences in how branched content was determined in each study (e.g. isomer-specific versus sum branched isomer quantification using linear and/or individual branched isomer standards). Nevertheless, differences due to ongoing maternal exposure to for instance PFHxS and PFOS precursors in China are likely since perfluorooctane sulfonyl fluoride-based chemistry is still used in China. 33 Maternal serum/plasma concentrations of PFHxS, PFOS, PFOA, PFNA, PFDA, and
PFUnDA during pregnancy and a few weeks after delivery both reflect placental and mother´s milk PFAA transfer, as shown by strong correlations between PFAA concentrations in maternal and cord blood, and between concentrations in maternal blood and mother´s milk. 9, 10, 26, 34, 35 We found positive correlations between maternal and infant PFAA concentrations, with weakening strength as chain length increased of both long-chain PFCAs and PFSAs (Table 3 ). This suggests that factors other than maternal concentrations become more important as determinants for infant PFAA concentrations as perfluoroalkyl chain length increases.
This is further supported by the decreased strength of association between maternal and infant concentrations with increased PFAA carbon chain length among exclusively breastfed infants, as determined in multiple log-linear regression analyses (Table 4) . Variation in maternal PFOA concentrations explained 53% of the infant concentration variation, whereas only 13% of the variation in infant PFUnDA was explained by maternal variation. For
PFHxS, 73% of the infant variation was explained by maternal variation, and the corresponding figure for PFOS was 36%. The short-chain PFHpA deviated from this pattern of chain-length dependency, showing a weaker infant/mother correlation than PFOA did (Table 3 ) and a weaker strength of association (Table 4) . For PFAA homologues with less strong infant/mother correlations and associations, contribution of infant exposure sources not studied by us may be important, including ingestion of dust, suction on materials containing PFASs, inhalation of fine particles/air, and skin exposure through use of personal care products. 4 To what degree these different exposure pathways contribute to total infant exposure has not been fully characterized, but the contribution of each component most probably varies with infant age. 4 Our results suggest that PFAA transfer efficiency from mother to infant decreases with increasing perfluoroalkyl chain length, as indicated by the infant/maternal serum concentration ratios (Table 3) . On average, PFHpA and PFOA showed higher concentrations in infants than in mothers, PFHxS concentrations were similar, and concentrations for PFNA, PFOS, PFDA and PFUnDA were lower in infants. This is in agreement with the previously observed chain length-dependent decrease in transfer efficiency over the placenta and from maternal blood to mother´s milk. 9, 32, 36, 37 It has been proposed that decreases in PFAA placental transfer with increased chain length may be due to decreases in water solubility and increases in PFAA affinity to serum albumin. 4, 37 It has also been hypothesized that there are chain length differences in active PFAA transport in the placenta, 4, 11 although this hypothesis has to our knowledge not been tested. Similarly, it is not known to what degree mammary gland active PFAA transport is involved in the carbon chain-dependency of PFAA transfer to mother´s milk.
In contrast to Fromme et al. 21 , our study does not include matched cord blood data. We have previously published cord whole blood data for PFOS, PFOA and PFNA in the Uppsala study 1996-99. 26 Assuming a distribution factor of 2 between serum and whole blood, average cord serum concentrations were 2-3 times lower than those in maternal serum sampled in late pregnancy, 26 which is in accordance with data from Fromme et al. 21 A comparison of published cord/maternal serum or plasma PFAA ratios with the infant/maternal serum PFAA ratios among Uppsala infants (Table 3) and German infants (plasma) show that the infant/maternal ratios generally are higher than the cord/maternal rations. 21, 32, 36 This strongly suggests that breastfeeding gives a significant contribution to the PFAA exposure of the infants.
The similar median ratios of infant/maternal linear and branched PFHxS, as well as of PFOS isomers (Table 3 ), show that linear and branched isomers were retained in the infants to a similar degree as in their mothers. A few studies have reported less efficient placental transfer of linear PFOS (relative to branched), but found no isomer specific differences in transfer via mother´s milk. 10, 32, 35 To our knowledge, only one study has reported placental transfer efficiencies of PFHxS isomers showing, contrary to PFOS, a more efficient transfer of the linear isomer than of the branched isomers. 33 Our results suggest that the more efficient trans-placental transfer of branched PFOS, and less efficient transfer of branched PFHxS, are "compensated for" after birth, presumably from mother´s milk, resulting in similar %br isomers in mothers and infants.
Impact of Duration of Breastfeeding, Gestational Age and Infant Weight Gain
Concentrations of PFOA, PFNA, PFDA, PFUnDA, PFHxS and PFOS were lower in exclusively bottle-fed infants than in exclusively breastfed infants, strongly suggesting that mother´s milk is an important source of infant exposure to all these PFAAs (Fig. 1) . The results are however uncertain since we only had 5 exclusively bottle-fed infants, but the importance of breastfeeding as an exposure source of all these PFAAs is supported by our findings of lower serum PFAA concentrations also among mixed breast-/bottle-fed infants (Fig. 1) . The lower PFAA concentrations in bottle-fed infants are most probably a net result of infant excretion and growth dilution of PFAAs accumulated in utero, and much lower PFAA exposures from infant formula than from mother´s milk. 38, 39 No exclusively bottle-fed infants were living in a district receiving contaminated drinking water, so it was not possible to determine the contribution of this potential exposure route.
The higher %br PFOS in the few exclusively bottle-fed infants than in exclusively breastfed infants (Fig. 1 ) is most probably a result of the higher placental transfer of branched PFOS isomers than of the linear isomer, and a "mother´s milk compensation" with the linear isomer among exclusively breastfed infants. 10, 32, 35 Branched PFOS isomers are preferentially excreted in urine in adults compared with the linear isomer, 40, 41 but excretion of different PFOS isomers in infants apparently was too slow to cause preferential retention of the linear isomer in bottle-fed infants. The reported lower trans-placental transfer efficiency of branched PFHxS isomers than of the linear isomer 33 did not result in lower %br PFHxS concentration in the exclusively bottle-fed infants (Fig. 1) . Assuming that the excretion of PFHxS was negligible during infancy, the results suggests that the transfer of branched PFHxS isomers to mother´s milk is not higher than transfer of the linear isomer.
In the multiple regression analyses of PFAA concentrations in exclusively breastfed infants, duration of breastfeeding explained <10% of the variation in infant PFAA concentrations, with estimated increases in serum concentrations of ≤10% per week of breastfeeding as the infant age at sampling increased from 11 to 18 weeks ( Table 4) .
Associations with breastfeeding were statistically significant for PFOA, PFNA and PFHxS.
The low variation in duration of breastfeeding (7 weeks Norway and USA, every month of breastfeeding was associated with a 3-6% increase in PFHxS, PFOS and PFOA in child serum. 16, 17 The lower contribution of breastfeeding in the older children is most probably an effect of excretion of maternally transferred PFAA and contribution of non-maternal sources of PFAA exposure during childhood.
Our results suggests that duration of in utero exposure influences infant concentrations of PFOA, PFNA and PFOS up to 2-4 months after delivery, since days of gestational age in general was positively associated with infant PFAA concentrations (Table 4) . However, the associations were fairly weak, explaining only 2-10% of the variation in infant concentrations of PFOA, PFNA and PFOS. An earlier study found strong positive correlations between fetal age and fraction of maternal PFAAs present in fetal tissue. 43 Residual confounding of the gestational age-PFAA associations cannot be excluded. For instance a study from Canada reported that increases in maternal gestational weight gain (GWG), which increases with gestational age, were associated with elevated cord blood PFOS and PFOA concentrations 44 Inclusion of maternal weight gain as a covariate in the regression models did however not change the associations between gestational age and PFOA, PFNA and PFOS serum concentrations in exclusively nursed infants (Supporting Information, Table A8 ). Birth weight, which is associated with gestational age, may be another potential confounder through influence on distribution volume of infant PFAAs. For PFNA and PFOS inclusion of birth weight as a covariate did not influence the associations with gestational age, but for PFOA the association became weaker (Supporting Information, Table A8 ).
Branched PFOS isomers increased on average with 1% per day of gestational age, whereas the linear isomer increased 0.75% per day of gestational age (Table 4) , supporting a higher placental transfer of branched as opposed to linear isomers. 32, 33 No significant change in branched and linear PFHxS per day of gestational age was observed, further supporting the low influence of gestational age on serum PFHxS concentrations in infants at 2-4 months of age (Table 4) .
It may be hypothesized that infant weight gain affects PFAA concentrations due to growth dilution of PFAA accumulated pre-and post-natally. However, the inverse association was only significant (p=0.03) for PFHpA (Table 4 ), explaining about 10% of variation in infant concentrations (Table 4) . Infant PFHpA concentrations decreased on average about 1% with each percentage of weight gain during the study period (Table 4 ). The infant weight gain effect on concentrations of other PFAAs than PFHpA was not large enough to be detected in the multiple regression analyses.
Impact of Contaminated Drinking Water.
In 2012, a PFAA contamination was discovered in Uppsala drinking water, with distribution of contaminated drinking water to some city districts dating back to at least 1996-1999. 31 The affected production wells were quickly taken out of production after the discovery of the contamination. In 2012-2014, the median PFHxS concentration was 80 ng L -1 in contaminated drinking water production wells, followed by PFOS (50 ng L -1 ), and PFBS and PFHxA (both 10 ng L -1 ). Our results suggest that maternal ingestion of the moderately PFHxS-and PFBScontaminated drinking water strongly influence serum concentrations of the two PFAAs in infants (Fig 2) . The adjusted mean infant serum concentrations of PFBS and PFHxS were about 3-fold higher among infants living in District 4, receiving >90% PFAA-contaminated drinking water between 1996 and 1999, than among infants living in the districts not receiving contaminated water (Fig. 2) .
Similarly as among Uppsala mothers, 31 no influence of contaminated drinking water on infant PFOS concentrations was observed (Supporting Information, Table A7 ), although PFOS concentrations in the contaminated drinking water were only slightly lower than those of PFHxS and much higher than PFBS concentrations. Taken together the results suggest that, in contrast to PFBS and PFHxS, maternal PFOS exposure sources other than drinking water were more important indirect determinants of infant PFAA concentrations.
%br PFHxS was significantly higher in infants living in Uppsala districts receiving 10-90% and >90% contaminated water than in infants living in the district receiving uncontaminated water (Fig. 2) . We have previously proposed that increased %br PFHxS in adult serum, compared to background in a population, may be an indicator for drinking water exposure to PFHxS originating from fire-fighting foams. 31 Our infant results suggest that enrichment of branched PFHxS persists also in infants of mothers exposed to drinking water PFHxS.
Strengths and Limitations
Our study includes data on PFBS, PFHxA, PFHpA, PFUnDA, PFDoDA, PFTrDA, PFTeDA In the GLM analyses the covariates "gestational age", "infant weight gain after birth" and "duration of breastfeeding" were included.
*Significantly different from district "Outside of Uppsala" in multiple linear regression analyses (p<0.05). PFBS: District "Outside Uppsala" N=30, 0% N=40, <10% N=2, 10-90% N=7, >90% N=9.
PFHxS: District "Outside Uppsala" N=31, 0% N=41, <10% N=2, 10-90% N=7, >90% N=10. 
Supporting Information
PFAAs included in the study (Table A1) . Target compounds and selected instrumental parameters for quantification of each compound by UPLC/ESI-MS/MS (Table A2 ). Summary of analysis of in-house reference material (pooled human serum) analyzed together with real samples to assess inter-batch precision (i.e. reproducibility) (Table A3) . PFCA concentrations measured in 3 replicates of NIST SRM 1957 compared to reference values (Table A4) . PFSA concentrations measured in 3 replicates of NIST SRM 1957 compared to reference values (Table A5 ). Method detection limits for PFASs analyzed in each of the three batches (Table   A6 ). Concentrations of PFAAs in serum from 2-4-month-old children sampled 1996-1999, living in different drinking water districts in the Uppsala County (Table A7 ). The influence of maternal weight gain during pregnancy and birth weight on percent change in serum PFAA concentrations per unit change of gestational age in exclusively breastfed infants (Table A8 ).
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